Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
Autori principali: | Flossmann, O, Jones, R, Jayne, DR, Luqmani, R |
---|---|
Natura: | Journal article |
Lingua: | English |
Pubblicazione: |
2006
|
Documenti analoghi
Documenti analoghi
-
Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
di: Mukhtyar, C, et al.
Pubblicazione: (2006) -
Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
di: Mukhtyar, C, et al.
Pubblicazione: (2008) -
Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
di: Saket Jha, et al.
Pubblicazione: (2019-01-01) -
Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
di: Zhi-Ying Li, et al.
Pubblicazione: (2020-08-01) -
A Case of Postcoronavirus Disease 2019 Antineutrophil Cytoplasmic Antibody-associated Vasculitis Successfully Treated with Rituximab
di: Mahmoud M. Mohamed, et al.
Pubblicazione: (2023-07-01)